Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
Farhat L. Khanim, Rachel E. Hayden, Jane Birtwistle et al. · 2009
Read Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia by Farhat L. Khanim, Rachel E. Hayden, Jane Birtwistle et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008147.txt.
Description
Farhat Khanim and colleagues paired two old drugs against a hard leukemia in PLOS ONE in 2009. Acute myeloid leukemia strikes mostly people over sixty, and standard care fails many of them. The pair joined a cholesterol drug, bezafibrate, with a hormone drug used for other ills.
Together, the two pushed leukemia cells to mature and die in ways neither did alone. Two cheap, well-known drugs with a fresh use would be a gift to older patients who cannot bear harsh chemotherapy. The lab results earned the pair a closer look in trials.
Catalog record
| CREATOR | Farhat L. Khanim, Rachel E. Hayden, Jane Birtwistle et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008147